Tanespimycin in Treating Women With Refractory Locally Advanced or Metastatic Breast Cancer

Summary

This phase II trial is studying how well tanespimycin works in treating women with refractory locally advanced or metastatic breast cancer. Drugs used in chemotherapy, such as tanespimycin, work in different ways to stop tumor cells from dividing so they stop growing or die

Timeline

Start

2005-09

Primary completion

2012-05

Completion

2012-05

Outcome

Outcome not reported

Stopped (Enrollment): “Closed to accrual before all 12 planned patients were enrolled.”

Drugs

Indications